Verteporfin
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2804 publications
Sustained Yap/Taz activation promotes aberrant alveolar epithelial cell differentiation and drives persistent fibrotic remodeling.
Journal: JCI insight
Published: June 09, 2026
Construction of hepatic stellate cells-targeted nanosystem of verteporfin for the effective treatment of liver fibrosis through mechanical signal modulation.
Journal: Nanotechnology
Published: May 01, 2026
Signals of Drug-Related Retinal Fibrosis: Findings From a 20-Year Disproportionality Analysis of Global Spontaneous Reports.
Journal: Translational vision science & technology
Published: April 13, 2026
Effects of LATS1/2 kinases inhibition on lung epithelial cells in a regeneration model.
Journal: Molecular and cellular biochemistry
Published: March 04, 2026
Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 03, 2026
Modulatory Effects of Bioactive Phytoconstituents on the Amplitude and Gating Properties of Membrane Ion Channels.
Journal: Molecules (Basel, Switzerland)
Published: March 02, 2026
Breaking bone-associated tumor vicious cycle through macrophage membrane-camouflaged nanodecoys for sonodynamic/epigenetic therapeutics of oral squamous cell carcinoma.
Journal: Journal of nanobiotechnology
Published: February 23, 2026
Stabilizing lysosome to facilitate verteporfin-based anticancer photodynamic therapy via trehalose co-assembled nanogel.
Journal: Colloids and surfaces. B, Biointerfaces
Published: February 11, 2026
In Silico Analysis of the Binding Mode of Verteporfin, a YAP-TEAD Interaction Inhibitor.
Journal: Chemical & pharmaceutical bulletin
Published: February 11, 2026
Last Updated: 06/30/2026